C1q/TNF-Related Protein5 (CTRP5) as a Biomarker to Predict Metabolic Syndrome and Each of Its Components.

Feiyu JiangMin YangXili ZhaoRui LiuMengliu YangDongfang LiuHua LiuHongting ZhengZhiming ZhuLing Li

Published in: International journal of endocrinology (2018)

Circulating CTRP5 is relative to the elevated risk of MetS in humans and may be in part through the effect of insulin resistance. This trial is registered with ChiCTR-OCS-13003185.

Keyphrases

insulin resistance
metabolic syndrome
high fat diet
adipose tissue
rheumatoid arthritis
phase iii
study protocol
polycystic ovary syndrome
uric acid
clinical trial
skeletal muscle
phase ii
high fat diet induced
type diabetes
cardiovascular risk factors
randomized controlled trial
glycemic control